ALS Drug Gets Support of FDA Advisers in Rare Second Review
A closely watched experimental drug for Lou Gehrig’s disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to...
Stay updated with breaking news from Greg Canter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A closely watched experimental drug for Lou Gehrig’s disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to...
The Food and Drug Administration is not required to follow the panel's advice, but its positive recommendation suggests an approval is likely later this month.
A panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig’s disease
A panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig's disease. The ruling Wednesday is a remarkable turnaround for the much-debated medication that was previously rejected by the same group earlier this year. The FDA previously held a meeting in March where the outside experts narrowly sided against Amylyx's drug, saying the company's data was unconvincing. Wednesday's meeting focused on new analyses which the company said strengthened its case for approval. Patients and their families have rallied behind Amylyx's drug, urging approva...
A panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig's disease.